Klebsiella pneumoniae clinical isolates resistant to carbapenems were recovered from 11 patients in the hospital of Sfax, Tunisia. The isolates were closely related as shown by pulsed-field gel electrophoresis, and they produced VIM-4 metallo-enzyme, CTX-M-15 extended-spectrum ␤-lactamase, and CMY-4 AmpC enzyme. The bla VIM-4 gene is part of a class 1 integron.
During the last decade, acquired metallo-␤-lactamases (MBLs) emerged among Pseudomonas aeruginosa isolates and other gram-negative nosocomial pathogens (2, 6, 7, 14, 15, 20, 27) . The most frequently acquired MBLs are the IMP and VIM types (15, 20) . Three other types of acquired MBLs in P. aeruginosa isolates from Brazil (SPM-1) (28) and Germany (GIM-1) (3) and in Acinetobacter baumannii isolates from Korea (SIM-1) (13) have recently been described.
The first member of the VIM family of determinants, VIM-1, was identified from a clinical isolate of P. aeruginosa in Verona, Italy (11) . Over the past few years, studies have reported the dissemination of VIM-type MBLs in Enterobacteriaceae (30) , suggesting the ongoing spread of these resistance determinants among more pathogens. Outbreaks of Klebsiella pneumoniae strains producing VIM-type MBLs have been reported recently in Greece (8) , France (10) , and Italy (16) .
We report the emergence of a multidrug-resistant K. pneumoniae isolate that produces the metallo-␤-lactamase VIM-4, extended-spectrum ␤-lactamase (ESBL) CTX-M-15, AmpC ␤-lactamase CMY-4, and class A ␤-lactamase TEM-1 in a Tunisian university hospital.
Between May and July 2005, 20 imipenem-resistant strains of K. pneumoniae were recovered from 11 patients from different wards. The index case was a 50-year-old woman who underwent placement of an indwelling double ureteral stent for acute purulent calculous pyelonephritis and received 12 days of treatment with cefotaxime. One month later, the patient developed a stent-associated infection. Carbapenem-resistant K. pneumoniae was recovered from her urine and blood. After treatment with colimycin and imipenem over 4 weeks and removal of the ureteral stent, the patient recovered. This strain was subsequently recovered from 10 other patients (Table 1 ). All infections were acquired in the hospital. Ten out of the 11 patients had received some kind of surgery, implying that the K. pneumoniae isolate could have been acquired in operating theaters, but no common source was identified.
Six of the 11 study patients were infected with a carbapenem-resistant isolate, and 4 of these died during their stay in the intensive care unit, with the K. pneumoniae infection being causative or contributory. The two patients with urinary tract infections were successfully treated with colimycin and imipenem.
The first isolate for each patient was included in this study. Susceptibility testing using the disk diffusion method showed that all isolates were highly resistant to all ␤-lactams and exhibited resistance to most non-␤-lactam antimicrobials tested (including aminoglycosides and ciprofloxacin), except for colis-tin. As all the K. pneumoniae isolates had similar antimicrobial susceptibility patterns, we investigated the clonal relationship of these strains by pulsed-field gel electrophoresis (PFGE) of SpeI-restricted genomic DNA. The PFGE results revealed that all K. pneumoniae strains isolated were genetically identical ( Fig. 1 ) (28) and were different from the profiles obtained for VIM-1-producing K. pneumoniae strains K1, K5, and K8 from Greece used as controls (8) .
All isolates were resistant to both aztreonam and imipenem. These isolates were positive by the EDTA disk synergy test, suggesting the presence of a class B enzyme (MBL), but this could not explain the high level of resistance to aztreonam. In view of the results of ␤-lactamase screening, we determined the MICs of cefotaxime, ceftazidime, cefepime, aztreonam, imipenem, and meropenem, with and without inhibitors (EDTA or clavulanic acid alone and in association), by agar dilution. Table 3 shows the MICs for the index case. The remainder of the strains were phenotypically identical. In the presence of EDTA, the MICs of imipenem decreased to 0.25 g/ml and those of meropenem to 0.06 g/ml, indicating the production of the metallo-␤-lactamase. Moreover, the MICs of extended-spectrum cephalosporins were reduced fourfold to eightfold, whereas the MICs of aztreonam were not significantly reduced. The ESBL phenotype was thus verified by the significant reduction of the MICs of aztreonam in the presence of clavulanic acid. Only the combination of two inhibitors, EDTA and clavulanic acid, restored the activities of the broadspectrum cephalosporins. The decrease in the MICs was more important for cefepime than for cefotaxime and ceftazidime, indicating the presence of an additional class C ␤-lactamase (Table 3) .
To analyze the genetic support of these various ␤-lactamase genes, conjugational transfers were done with Escherichia coli J53-2 Rif r as the recipient and with selection on aztreonam (4 g/ml), cefotaxime (4 g/ml), or imipenem (2 g/ml) and rifampin (250 g/ml). Two different antimicrobial resistance phenotypes were obtained, the first on aztreonam suggesting the presence of an ESBL and the second on cefotaxime or imipenem suggesting the presence of the metallo-␤-lactamase. Plasmid extraction showed the presence of two large plasmids (Ͼ130 kb) in the K. pneumoniae isolate (data not shown). By PCR, the smallest encoded both CMY-2-type and VIM-type enzymes in the transconjugants obtained on imipenem or cefotaxime, whereas the largest (transferred on aztreonam) encoded both CTX-M-type and TEM-type ␤-lactamases (data not shown).
To confirm the presence and the sequences of the three ␤-lactamases (VIM-4, CTX-M-15, and CMY-4), we did cloning experiments. DNA fragments obtained from genomic DNA partially digested with Sau3A were ligated into the vector pACYC184 digested with BamHI. E. coli DH10B (Invitrogen SARL, Cergy-Pontoise, France) transformants were selected on Mueller-Hinton agar supplemented with 50 g/ml of chloramphenicol and 2 g/ml of ceftazidime. Three different antimicrobial resistance phenotypes were obtained and were consistent with the production of MBL enzyme, ESBL, and cephalosporinase. The identification of these ␤-lactamase-encoding genes confirmed the presence of VIM-4, CTX-M-15, and CMY-4 enzymes. Further nucleotide sequence analysis of the MBL determinant revealed that bla VIM-4 was part of a class 1 integron as previously described (12, 22, 26, 29) . The cassette region contained (from 5Ј to 3Ј) bla VIM-4 , aacA7, dhfrA1, and aadA1 genes. This structure was similar to those reported for VIM-1-producing P. aeruginosa, E. coli, and K. pneumoniae (8) (9) (10) (11) 17) . This is the first report of MBLs in Tunisia (1). The simultaneous production of three ␤-lactamases (VIM-4, CMY-4, and CTX-M15) by K. pneumoniae clinical isolates is noteworthy. The coexistence of two enzymes, an MBL and a non-MBL extended-spectrum ␤-lactamase, in the same strain has been previously documented for Enterobacteriaceae, with both VIM-1 and a CTX-M-type ␤-lactamase (23), VIM-1 and SHV-5 (10), SHV-12 and VIM-4 (16), VIM-2 and IBC-1 (7), IMP-1 and CTX-M-2 (15), VIM-12 and a CMY-type cephalosporinase (21) , and VIM-1 and CMY-13 (18) .
The emergence of the bla VIM-4 gene indicates the wide circulation of MBL-encoding genes and poses challenges for the treatment of hospital infections due to gram-negative bacteria. The outbreak of imipenem-resistant K. pneumoniae occurred in our hospital over a 3-month period. From July 2005 until July 2006, only two other K. pneumoniae isolates producing MBLs were recovered from two patients. Although the bla VIMpositive isolates were still confined to these units and spread at a low rate in our hospital, strict infection control measures against such isolates should be implemented to prevent their further dissemination.
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